108 related articles for article (PubMed ID: 3725235)
1. Animal studies on the in vivo stability of 211At-labelled albumin particles.
Wunderlich G; Henke E; Iwe B; Franke WG; Fischer S; Dreyer R
Nucl Med Commun; 1986 Apr; 7(4):211-4. PubMed ID: 3725235
[TBL] [Abstract][Full Text] [Related]
2. Determination of absorbed dose to blood, kidneys, testes and thyroid in mice injected with 211At and comparison of testes mass and sperm number in x-irradiated and 211At treated mice.
Harrison A; Royle L
Health Phys; 1984 Feb; 46(2):377-83. PubMed ID: 6693268
[TBL] [Abstract][Full Text] [Related]
3. Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice.
Vergote I; Larsen RH; De Vos L; Winderen M; Ellingsen T; Bjørgum J; Hoff P; Aas M; Tropé C; Nustad K
Gynecol Oncol; 1992 Dec; 47(3):358-65. PubMed ID: 1473750
[TBL] [Abstract][Full Text] [Related]
4. alpha-Particle track autoradiography for localization of a 211At-astatinated drug.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1983 Mar; 39(3):337-9. PubMed ID: 6825808
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
Vergote I; Larsen RH; de Vos L; Nesland JM; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K
Gynecol Oncol; 1992 Dec; 47(3):366-72. PubMed ID: 1473751
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of malignant ascites in vivo by 211At-labelled microspheres].
Bredow J; Kretzschmar M; Wunderlich G; Dörr W; Pohl T; Franke WG; Kotzerke J
Nuklearmedizin; 2004 Mar; 43(2):63-8. PubMed ID: 15029267
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
[TBL] [Abstract][Full Text] [Related]
8. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
9. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability.
Schiller E; Bergmann R; Pietzsch J; Noll B; Sterger A; Johannsen B; Wunderlich G; Pietzsch HJ
Nucl Med Biol; 2008 Feb; 35(2):227-32. PubMed ID: 18312833
[TBL] [Abstract][Full Text] [Related]
10. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.
Link EM; Carpenter RN
Cancer Res; 1990 May; 50(10):2963-7. PubMed ID: 2334899
[TBL] [Abstract][Full Text] [Related]
11. [Effects of At-211 alpha irradiation on Ehrlich ascites tumor cells].
Shmakova NL; Norseev IuV; Waĭnson AA; Siuch Z; Fadeeva TA; Fomenkova TE; Khalkin VA; Cherebatenko AP
Eksp Onkol; 1990; 12(3):58-60. PubMed ID: 2111764
[TBL] [Abstract][Full Text] [Related]
12. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
Link EM; Michalowski AS; Rösch F
Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma.
Brown I; Carpenter RN; Mitchell JS
Int J Appl Radiat Isot; 1984 Sep; 35(9):843-7. PubMed ID: 6480147
[TBL] [Abstract][Full Text] [Related]
14. Measuring astatine-211 distributions with SPECT.
Turkington TG; Zalutsky MR; Jaszczak RJ; Garg PK; Vaidyanathan G; Coleman RE
Phys Med Biol; 1993 Aug; 38(8):1121-30. PubMed ID: 8367523
[TBL] [Abstract][Full Text] [Related]
15. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
16. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.
Zalutsky MR; Vaidyanathan G
Curr Pharm Des; 2000 Sep; 6(14):1433-55. PubMed ID: 10903402
[TBL] [Abstract][Full Text] [Related]
17. Preparation of HSA microspheres in a one-step thermal denaturation of protein aerosol carried in gas-medium.
Przyborowski M; Lachnik E; Wiza J; Licińska I
Eur J Nucl Med; 1982; 7(2):71-2. PubMed ID: 6211358
[TBL] [Abstract][Full Text] [Related]
18. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
19. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
20. Alpha-particle track autoradiographic study of the distribution of a [211At]-astatinated drug in normal tissues of the mouse.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1985 Jul; 41(7):925-8. PubMed ID: 4007129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
